Office-Based Screening for Dementia in Parkinson Disease-Reference-Cited by-同舟云学术

Office-Based Screening for Dementia in Parkinson Disease

Published:2018-06-01 Issue:6 Volume:75 Page:704
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Dawson Benjamin K.¹²,Fereshtehnejad Seyed-Mohammad¹³,Anang Julius B. M.¹,Nomura Takashi⁴,Rios-Romenets Silvia¹,Nakashima Kenji⁴,Gagnon Jean-François⁵⁶,Postuma Ronald B.¹

Affiliation:

1. Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada

2. Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada

3. Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden

4. Division of Neurology, Department of Brain and Neurosciences, Tottori University, Tottori, Japan

5. Centre d’Études Avancées en Médecine du Sommeil, Hôpital du Sacré-Coeur de Montréal, Montréal, Quebec, Canada

6. Department of Psychology, Université du Québec à Montréal, Montreal, Quebec, Canada

Publisher

American Medical Association (AMA)

Subject

Clinical Neurology

Reference32 articles.

1. Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson’s disease patients.;Auyeung;J Neurol Neurosurg Psychiatry,2012

2. Risk of dementia in Parkinson’s disease: a community-based, prospective study.;Aarsland;Neurology,2001

3. The Sydney multicentre study of Parkinson’s disease: progression and mortality at 10 years.;Hely;J Neurol Neurosurg Psychiatry,1999

4. Dementia and survival in Parkinson disease: a 12-year population study.;Buter;Neurology,2008

5. Parkinson’s disease dementia: diagnostic criteria and risk factor review.;Vasconcellos;J Clin Exp Neuropsychol,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticipating Tomorrow: Tailoring Parkinson's Symptomatic Therapy Using Predictors of Outcome;Movement Disorders Clinical Practice;2024-05-30

2. Spontaneous brain activity in the hippocampal regions could characterize cognitive impairment in patients with Parkinson's disease;CNS Neuroscience & Therapeutics;2024-04

3. Original research: initial development of a pragmatic tool to estimate cognitive decline risk focusing on potentially modifiable factors in Parkinson’s disease;Frontiers in Neuroscience;2023-10-24

4. Neuropsychiatric Symptoms and Parkinson Disease;Neurology;2023-09-19

5. Novel exposition on reinforcement mechanism of nanoparticles doped gels for early diagnosis of Parkinson's disease;Composites Science and Technology;2023-08